Althea NCM 116a
Althea NCM 116a
Althea NCM 116a
METABOLIC &
ENDOCRINE DISORDER:
Part II
Althea A. Alejano, RN, MAN
02 March 2021
Intended Learning Outcomes
• After taking this lesson, the learners shall:
1. Relate clinical manifestations to the anatomy and
physiology of organs affected among patients with
metabolic and endocrine disorders;
2. Identify medical, surgical and nursing management
to patients with metabolic and endocrine disorders;
3. Use the nursing process as a framework for care of
the patient with metabolic and endocrine disorders.
HEPATIC ENCEPHALOPATHY
AND COMA
• ECG
• Fetor Hepaticus
Medical Management
Lactulose (Cephulac)
intravenous administration of glucose to
minimize protein breakdown
administration of vitamins to correct deficiencies
correction of electrolyte imbalances (especially
potassium)
What are the possible
NURSING DIAGNOSIS for
patients with hepatic
encephalopathy?
Nursing Management
maintaining a safe environment to prevent
injury, bleeding, and infection
administers the prescribed treatments and
monitors the patient for the many potential
complications
communicates with the patient’s family to
keep them informed about the patient’s
status, and supports them by explaining
the procedures and treatments that are
part of the patient’s care
OTHER MANIFESTATIONS OF LIVER DYSFUNCTION
• alpha interferon: for chronic type B viral hepatitis but has significant
side effects such as bone marrow suppression, thyroid dysfunction,
alopecia, and bacterial infections.
• Antiviral agents (lamivudine [Epvir] and adefovir [Hepsera]) oral nucleoside
analogs: approved for use
• Bed rest to gradual activity as tolerated
• Adequate nutrition should be maintained
NON-VIRAL HEPATIC
DISORDERS
TOXIC HEPATITIS
• exposure to hepatotoxic chemicals, • Management
medications, or other agents
1. Client may die of fulminant hepatic
• Recovery is rapid if the hepatotoxin is failure unless receives a liver transplant.
identified early and removed
2. Therapy is directed toward
• no effective antidotes
• restoring and maintaining fluid and electrolyte
• Manifestations balance
• Anorexia • blood replacement
• Nausea • comfort and supportive measures
• vomiting
• jaundice and hepatomegaly
DRUG-INDUCED HEPATITIS
• onset is abrupt, with chills, fever, rash, pruritus, arthralgia, anorexia, and nausea
• jaundice and dark urine and an enlarged and tender liver
• . If fever, rash, or pruritus occurs from any medication, its use should be stopped
immediately
• Common medications
• anesthetic agents (Halothane) : Isoflurane is the anesthetic of choice for those
with liver disease
• medications used to treat rheumatic and musculoskeletal disease
• Antidepressants
• psychotropic medications
• Anticonvulsants
• anti-tuberculosis agents (Isoniazid)
• Acetaminophen
• certain antibiotics
• Antimetabolites
FULMINANT HEPATIC FAILURE
• the clinical syndrome of sudden and severely impaired liver function in a previously
healthy person • Manifestations
• 3 Categories 1. Jaundice and profound
1. hyperacute liver failure-the duration of jaundice before the onset of anorexia
encephalopathy is 0 to 7 days 2. coagulation defects
2. acute liver failure-8 to 28 days
3. renal failure and
3. subacute liver failure - 28 to 72 days
electrolyte disturbances
• prognosis for fulminant hepatic failure is much worse than for chronic liver failure
• Common causes: 4. infection
• toxic medications (eg, acetaminophen) 5. Hypoglycemia
• chemicals (eg, carbon tetrachloride) 6. encephalopathy
• metabolic disturbances (Wilson’s disease, a hereditary syndrome with 7. cerebral edema
deposition of copper in the liver)
• structural changes (Budd-Chiari syndrome, an obstruction to outflow in major
hepatic veins).
Management of Fulminant Hepatic Failure
ASSESS
DIAGNOSE
PLAN
INTERVENE
EVALUATE
Cancer of the Liver
• PRIMARY LIVER TUMORS • LIVER METASTASES
• associated with chronic liver disease, • 50% of all advanced cancer cases
hepatitis B and C infections, and cirrhosis
• Hepatocellular carcinoma (HCC) – most
• Malignant tumors are likely to
common reach the liver eventually, by way
• Other types: cholangiocellular carcinoma of the portal system or lymphatic
and combined hepatocellular and channels, or by direct extension
cholangiocellular carcinoma from an abdominal tumor
• Risk factor • The liver apparently is an ideal
• Cigarette smoking + alcohol
place for these malignant cells to
• aflatoxin, a metabolite of the fungus
Aspergillus flavus thrive
Clinical Assessment & Medical
Manifestations Diagnostic Findings Management
• nausea, vomiting, and weight loss leukocytes migrate into the infected area
• dull abdominal pain and tenderness
abscess cavity full of a liquid containing
on RUQ living and dead
• Hepatomegaly, jaundice, anemia, and leukocytes, liquefied liver cells, and
bacteria
pleural effusion
Assessment and
Medical Nursing
Diagnostic
Findings Management Management
ASSESS
DIAGNOSE
PLAN
INTERVENE
EVALUATE
Disorders of the Pancreas
CHRONIC • Clinical Manifestations
• recurring attacks of severe upper
PANCREATITIS abdominal and back pain,
• an inflammatory disorder characterized accompanied by vomiting
by progressive anatomic and functional • Pain not relieved by opioids
destruction of the pancreas
• Steatorrhea
• Cells are replaced by fibrous tissues due
to pancreatitis – mechanical obstruction • Diagnostic: ERCP
• Cause: long-term alcohol consumption
Surgical
Medical Management
Management
PLAN
INTERVENE
• The pancreas contains the islets (islands) of Langerhans, small nests of cells that
secrete directly into the bloodstream and therefore are part of the endocrine system
• two types of tumors of the pancreatic islet cells are known:
1. those that secrete insulin (insulinoma)
2. those in which insulin secretion is not increased (“nonfunctioning” islet cell cancer)
• . Insulinomas produce hypersecretion of insulin and cause an excessive rate of
glucose metabolism – hypoglycemia - f weakness, mental confusion, and seizures
• Surgical Management
• removal of the tumor
• partial pancreatectomy (tail or body)
ULCEROGENIC
HYPERINSULINISM
TUMORS
1. Health History
Exposure to hepatotoxic substance
Exposure to hepatotoxins (industrial
chemicals)
Lifestyle
Family History
Medical and Surgical history
2. Physical Assessment
Diagnostic
Evaluation
1. Liver Function Tests
Serum aminotransferases
(transaminases)
Alanine aminotransferase (ALT) -
serum glutamic-pyruvic
transaminase [SGPT]
aspartate aminotransferase (AST)
- serum glutamic-oxaloacetic
transaminase [SGOT]
gamma glutamyl transferase
(GGT) - G-glutamyl transpeptidase
2. Liver Biopsy
3. Others
UTZ
CT scan
MRI
Laparoscopy
Other Diagnostic Tests
HEPATIC
DYSFUNCTION
JAUNDICE
• bilirubin concentration in the blood
is abnormally elevated, all the body
tissues, including the sclerae and
the skin, become yellow-tinged or
greenish-yellow
• To control hemorrhage
• pressure is exerted on the
cardia (upper orifice of the
stomach) and against the
bleeding varices by a
double-balloon tamponade
(Sengstaken-Blakemore
tube)
ENDOSCOPIC SCLEROTHERAPY
• a sclerosing agent is
injected through a fiberoptic
endoscope into the bleeding
esophageal varices to
promote thrombosis and
eventual sclerosis.
ESOPHAGEAL BANDING THERAPY
(VARICEAL BAND LIGATION)
• a modified endoscope
loaded with an elastic
rubber band is passed
through an overtube
directly onto the varix (or
varices) to be banded
TRANSJUGULAR INTRAHEPATIC
PORTOSYSTEMIC SHUNTING
• a method of treating
esophageal varices in
which a cannula is
threaded into the portal
vein by the transjugular
route
SURGICAL MANAGEMENT
• Surgical Bypass Procedures
• Surgical decompression of the portal circulation
can prevent variceal bleeding if the shunt remains
patent
• distal splenorenal shunt made between the splenic
vein and the left renal vein after splenectomy
• mesocaval shunt is created by anastomosing the
superior mesenteric vein to the proximal end of the
vena cava or to the side of the vena cava using
grafting material
• Portacaval shunts divert all portal flow to the vena
cava via end-to-side or side-to-side approaches, so
they are considered nonselective shunts
• If the cause of portal hypertension is the rare Budd-
Chiari syndrome or other venous obstructive disease,
a portacaval or a mesoatrial shunt may be performed
ESOPHAGEAL VARICES: Nursing
Management
• Monitor physical condition
• evaluate emotional responses and cognitive status
• vital signs
• nutritional and neurologic status
• Complete rest of the esophagus – parenteral nutrition
• Gastric suction
• Frequent oral hygiene and moist sponges to the lips
• monitors the blood pressure
• Vitamin K therapy and multiple blood transfusions
• Provision of quiet environment
• Provides support and explanations regarding medical and nursing interventions
Summary of
Management
End of Presentation
CARE OF CLIENTS WITH
INTESTINAL AND RECTAL
DISORDERS
Althea A. Alejano, MAN, RN
23 February 2021
Intended Learning Outcomes
After taking this lesson, the learners shall:
1. Compare small bowel and large bowel obstruction
with regard to their pathophysiology, clinical
manifestations and management;
2. Describe colorectal and anorectal disorders in
terms of its pathophysiology, clinical
manifestations and management;
3. Identify health care teaching needs of clients with
intestinal disorders;
4. Utilize the nursing process in the care of clients
with intestinal disorders.
Where does obstruction commonly occurs? Is it in
the small bowel? Or in the large bowel?
CARE OF CLIENTS WITH
INTESTINAL DISORDERS
Intestinal Obstruction
• Presence of blockage
• Types of blockage:
Mechanical Obstruction Functional Obstruction
Intussusception Amyloidosis
polypoid tumors and neoplasms muscular dystrophy
stenosis, endocrine disorders (DM)
Strictures neurologic disorders (Parkinson’s
Adhesions disease)
Hernias
abscesses
Mechanical Obstruction
Intestinal Obstruction
Small Bowel Large Bowel
Pathophysiology Accumulation of intestinal contents, fluid, and gas results in an accumulation of intestinal contents, fluid, and
gas proximal to the obstruction
Increase in the intestinal lumen –decrease in
venous and arteriolar capillary pressure can lead to severe distention and perforation unless some
gas and fluid can flow back through the ileal valve.
edema, congestion, necrosis, and eventual
rupture or perforation of the intestinal wall blood supply is cut off; however, intestinal strangulation and
necrosis (ie, tissue death) occur; this condition is life
threatening
Medical • Decompression of the bowel through a • colonoscopy - to untwist and decompress the
Management nasogastric or small bowel tube bowel
• Surgical Intervention • Surgical intervention
• repairing the hernia or dividing • Cecostomy - for patients who are poor
the adhesion surgical risks and urgently need relief from
• removal of affected bowel with the obstruction
anastomosis • surgical resection to remove the
obstructing lesion
• temporary or permanent colostomy
• Ileoanal anastomosis
Intestinal Obstruction
Small Bowel Large Bowel
Cancer cells may break away from the primary tumor and spread
to other parts of the body (most often to the liver)
Clinical Most common:
• change in bowel habits
Manifestations • passage of blood in the stools
• passage of blood in the stools
• unexplained anemia, anorexia, weight loss, and fatigue
• right-sided lesions
• dull abdominal pain
• melena (ie, black, tarry stools)
• left-sided lesions
• associated with obstruction (ie, abdominal pain and cramping, narrowing
stools, constipation, and distention)
• bright red blood in the stool.
• rectal lesions
• tenesmus (ie, ineffective, painful straining at stool)
• rectal pain
• feeling of incomplete evacuation after a bowel movement
• alternating constipation and diarrhea
• bloody stool
Assessment & • Abdominal and rectal examination
Diagnostic Findings • fecal occult blood testing, barium enema,
proctosigmoidoscopy, and colonoscopy
• sigmoidoscopy with biopsy or cytology smears
• Carcinoembryonic antigen (CEA)
Complications • partial or complete bowel obstruction
• Hemorrhage
• Perforation, abscess formation, peritonitis, sepsis,
and shock
Medical ADJUVANT THERAPY: chemotherapy, radiation
Management therapy, immunotherapy, or multimodality therapy
(Depends on stage) • Dukes’ class C colon cancer is the 5-
fluorouracil plus levamisole regimen
• Dukes’ class B or C rectal cancer are given 5-
fluorouracil and high doses of pelvic
irradiation.
• Radiation therapy is used before, during,
and after surgery
• Irradiation for inoperative or unresectable
tumors (Intracavity and implantable devices
to deliver radiation)
Surgical Interventions
diet high in smoked foods and low in fruits and vegetables may
increase the risk
Other factors: e chronic inflammation of the stomach, pernicious
anemia, achlorhydria, gastric ulcers, H. pylori infection, and genetics
Clinical Manifestations
o Asymptomatic at early stage
o Progressive stage: anorexia, dyspepsia (indigestion), weight
loss, abdominal pain, constipation, anemia, and nausea and
vomiting
Assessment and Diagnostic Findings
o Endoscopy for biopsy and cytologic washings
o barium x-ray examination of the upper GI tract
o computed tomography (CT) scan, bone scan, and liver scan – to
determine metastasis
Medical Management
o No successful treatment
o tumor can be removed while it is still localized to the stomach
o Palliative care
DISORDERS O F THE
ESOPHAGUS
Althea A. Alejano, MAN, RN
February 2021
Let Us Review:
• When is the perfect time to collect specimen for fecalysis?
• What are your nursing interventions after the patient had undergone barium
swallow?
• What are your nursing responsibilities if the patient is for CT scan whole
abdomen?
Intended Learning Outcomes:
•
1. Identify physical and psychosocial needs of patients with esophageal disorders and
corresponding nursing management;
2. Utilize the nursing care process as a framework for care of patients with esophageal
disorders.
Disorders of the Esophagus
- begins at the base of the pharynx and ends about 4 cm below the diaphragm
1. DYSPHAGIA
most common symptom of esophageal disease
an uncomfortable feeling that a bolus of food is caught in the upper esophagus (before it
eventually passes into the stomach)
acute pain on swallowing (odynophagia)
pathologic conditions of the esophagus, including motility disorders (achalasia, diffuse
spasm), gastroesophageal reflux, hiatal hernias, diverticula, perforation, foreign bodies,
chemical burns, benign tumors, and carcinoma
2. ACHALASIA
absent or ineffective peristalsis of the Assessment and Diagnostic Findings
distal esophagus, accompanied by failure o Barium Swallow
of the esophageal sphincter to relax in
o CT of esophagus
response to swallowing
o Endoscopy
occurs most often in people 40 years of
age or older
Management
Clinical Manifestations o eat slowly and to drink fluids with meals
o difficulty in swallowing both liquids and solids o calcium channel blockers and nitrates have been used to
o sensation of food sticking in the lower portion of decrease esophageal pressure and improve swallowing
the esophagus o Injection of botulinum toxin (Botox) to quadrants of the
o chest pain and heartburn (pyrosis) esophagus via endoscopy has been helpful because it
inhibits the contraction of smooth muscle
o secondary pulmonary complications from
o treated conservatively by pneumatic dilation to stretch the
aspiration of gastric contents
narrowed area of the esophagus
o esophagomyotomy – surgery
3. DIFFUSE SPASM: motor disorder of the esophagus
Management
may result from stab or bullet wounds of the neck or o broad-spectrum antibiotic therapy
chest, trauma from motor vehicle crash, caustic injury
from a chemical burn (described later), or inadvertent o nasogastric tube is inserted
puncture by a surgical instrument during examination or
dilation
o Parenteral nutrition is preferred to
gastrostomy
Clinical Manifestations
o Surgery may be necessary to close the
o Dysphagia
wound
o Fever
o Leukocytosis
o severe hypotension
Assessment and Diagnostic Findings
o Diagnostic x-ray studies and fluoroscopy
7. FOREIGN BODIES
a precancerous condition that, if left untreated, can arise anywhere along the esophagus
result in adenocarcinoma of the esophagus, which
has a poor prognosis Leiomyoma (tumor of the smooth muscle) –
most common lesion; can occlude the lumen of
Clinical Manifestations
the esophagus
o Symptoms of GERD with notably frequent
heartburn Asymptomatic
Assessment and Diagnostic Findings Management:
o esophagogastroduodenoscopy (EGD) with o Small lesions are excised during
biopsy esophagoscopy
Management o lesions that occur within the wall of the
o repeat EGD in 6 to 12 months if with cell esophagus may require treatment via a
changes thoracotomy
o Medical and surgical management is similar to
that for GERD
12. CANCER OF THE ESOPHAGUS
➢ Complications
o Hypertension
o fecal impaction
o hemorrhoids and fissures
o megacolon
➢ Medical Management
o Education
o bowel habit training
o increased fiber and fluid intake
o judicious use of laxatives
o Routine exercise
o addition to the diet of 6 to 12 teaspoonfuls of unprocessed bran is recommended
o Enemas and rectal suppositories are generally not recommended
➢ Nursing Management
o Gather pertinent data through
health history interview
➢ onset and duration of
constipation
➢ current and past elimination
patterns
➢ patient’s expectation of
normal bowel elimination
➢ lifestyle information
o exercise and
activity level
o Occupation
o food and fluid intake
o stress level
➢ Past medical and surgical
history
➢ current medications
➢ laxative and enema use
o Patient education and health
promotion
➢ Nursing Goals
o restoring or maintaining a regular pattern of elimination
o ensuring adequate intake of fluids and high-fiber foods
o learning about methods to avoid constipation
o relieving anxiety about bowel elimination patterns
o avoiding complications
DIARRHEA
➢ increased frequency of bowel movements (more than three per day), increased amount of
stool (more than 200 g per day), and altered consistency (ie, looseness) of stool
➢ associated with urgency, perianal discomfort, incontinence, or a combination of these
factors
➢ CAUSES
o Any condition that causes increased
intestinal secretions, decreased mucosal
absorption, or altered motility can produce
diarrhea
▪Irritable bowel syndrome (IBS)
▪inflammatory bowel disease (IBD)
▪lactose intolerance
o certain medications
▪ thyroid hormone replacement
▪ stool softeners and laxatives
▪ antibiotics
▪ chemotherapy
▪ antacids
o certain tube feeding formulas
o metabolic and endocrine disorders
▪ diabetes
▪ Addison’s disease
▪ thyrotoxicosis
o viral or bacterial infectious processes
▪ dysentery
▪ shigellosis
▪ food poisoning
o nutritional and malabsorptive disorders
▪ Celiac disease
▪ celiac disease
o anal sphincter defect
o Zollinger-Ellison syndrome
o paralytic ileus
o intestinal obstruction
o acquired immunodeficiency syndrome
(AIDS)
➢ may be ACUTE or CHRONIC
➢ Pathophysiology
o Secretory diarrhea
▪ usually high-volume diarrhea
▪ caused by increased production and secretion of water and
electrolytes by the intestinal mucosa into the intestinal lumen
o Osmotic diarrhea
▪ occurs when water is pulled into the intestines by the osmotic
pressure of unabsorbed particles, slowing the reabsorption of water
o Mixed diarrhea
▪ caused by increased peristalsis (usually from IBD)
▪ a combination of increased secretion and decreased absorption in
the bowel
➢ Clinical Manifestations
o increased frequency and fluid content of stools
o abdominal cramps
o distention
o intestinal rumbling (ie, borborygmus)
o anorexia
o thirst
o Painful spasmodic contractions of the anus and ineffectual straining
o Stool characteristics
▪ small bowel disease: Watery stools
▪ disorders of the colon: loose, semisolid stools
▪ intestinal malabsorption: Voluminous, greasy stools
▪ inflammatory enteritis or colitis: presence of mucus and pus in the stools
▪ diagnostic of pancreatic insufficiency: Oil droplets on the toilet water
➢ Assessment and Diagnostic Findings
o complete blood cell count
o chemical profile
o urinalysis
o routine stool examination
o stool examinations for infectious or parasitic organisms, bacterial toxins, blood,
fat, and electrolytes
o Endoscopy or barium enema
➢ Complications
o potential for cardiac dysrhythmias
▪ significant fluid and electrolyte loss (especially loss of potassium)
o Urinary output of less than 30 mL per hour for 2 to 3 consecutive hours
o muscle weakness
o paresthesia
ohypotension
oanorexia
odrowsiness with a potassium level of less than 3.0 mEq/L (3 mmol/L)
oDecreased potassium levels cause cardiac dysrhythmias that can lead to death
▪ atrial and ventricular tachycardia
▪ ventricular fibrillation
▪ premature ventricular contractions
➢ Medical Management
o controlling symptoms
o preventing complications
o eliminating or treating the underlying disease
➢ Nursing Management
o assessing and monitoring the characteristics and pattern of diarrhea
o health history addresses the patient’s medication therapy, medical and surgical
history, and dietary patterns and intake, exposure to acute illness, and travel
o Assessment includes abdominal auscultation and palpation for abdominal
tenderness
o Inspection of the abdomen and mucous membranes and skin
o Obtain stool samples for testing
o encourages bed rest and intake of liquids and foods low in bulk until the acute
attack subsides
o recommends a bland diet of semisolid and solid foods
o avoid caffeine, carbonated beverages, and very hot and very cold foods, because
they stimulate intestinal motility
o restrict milk products, fat, whole-grain products, fresh fruits, and vegetables for
several days
o administers antidiarrheal medications such as diphenoxylate (Lomotil) and
loperamide (Imodium) as prescribed
o Intravenous fluid therapy
o closely monitor serum electrolyte levels
o immediately reports evidence of dysrhythmias or a change in the level of
consciousness
o follow a perianal skin care routine to decrease irritation and excoriation
FECAL INCONTINENCE
➢ involuntary passage of stool from the rectum
➢ factors influencing fecal continence
o the ability of the rectum to sense and accommodate stool
o the amount and consistency of stool
o the integrity of the anal sphincters and musculature
o rectal motility
➢ Pathophysiology
o trauma
▪ after surgical procedures involving the rectum
o a neurologic disorder
▪ stroke
▪ multiple sclerosis
▪ diabetic neuropathy
▪ dementia
o inflammation
o infection
o radiation treatment
o fecal impaction
➢ pelvic floor relaxation
o laxative abuse
o Medications
o advancing age
▪ weakness or loss of anal or rectal muscle tone
➢ Clinical Manifestations
o occasional urgency and loss of control, or complete incontinence
o poor control of flatus
o diarrhea
o constipation
➢ Nursing Management
o health history
o examination of the rectal area.
o initiates a bowel-training program that involves setting a schedule to establish
bowel regularity
o use suppositories to stimulate the anal reflex
o Maintaining skin integrity (perianal area)
o assists the patient and family to accept and cope with this chronic situation
➢ Pathophysiology
o Related factors
▪ neurologic regulatory
system
▪ infection or irritation
▪ vascular or metabolic
disturbance
➢ Clinical Manifestations
o alteration in bowel patterns—constipation, diarrhea, or a combination of both
o Pain, bloating, and abdominal distention
o abdominal pain precipitated by eating and relieved by defecation
➢ Medical Management
o Goals
▪ relieving abdominal pain
▪ controlling the diarrhea or constipation
▪ reducing stress
o Food restrictions (beans, caffeinated products, fried foods, alcohol, spicy foods)
o healthy, high-fiber diet
o Exercise
o stress reduction or behavior-modification program
o Pharmacotherapy
▪ Hydrophilic colloids (ie, bulk)
▪ antidiarrheal agents (eg, loperamide)
▪ Antidepressants
▪ Anticholinergics and calcium channel blockers
➢ Nursing Management
o provide patient and family education
o emphasizes teaching and reinforces good dietary habits
o encouraged to eat at regular times and to chew food slowly and thoroughly
o adequate fluid intake
▪ fluid should not be taken with meals because this results in abdominal
distention
o Discourage alcohol use and cigarette smoking
CONDITIONS OF MALABSORPTION
➢ inability of the digestive system to absorb one or more of the major vitamins
(especially vitamin B12), minerals (ie, iron and calcium), and nutrients (ie,
carbohydrates, fats, and proteins)
➢ Common cause: Diseases of the small intestine
➢ Pathophysiology
o Mucosal (transport) disorders causing generalized malabsorption (eg, celiac
sprue, regional enteritis, radiation enteritis)
o Infectious diseases causing generalized malabsorption (eg, small bowel
bacterial overgrowth, tropical sprue, Whipple’s disease)
o Luminal problems causing malabsorption (eg, bile acid deficiency, Zollinger-
Ellison syndrome, pancreatic insufficiency)
o Postoperative malabsorption (eg, after gastric or intestinal resection)
o Disorders that cause malabsorption of specific nutrients (eg, disaccharidase
deficiency leading to lactose intolerance)
➢ Clinical Manifestations
o hallmarks of malabsorption syndrome: diarrhea or frequent, loose, bulky, foul-
smelling stools that have increased fat content and are often grayish
o abdominal distention
o pain
o increased flatus
o weakness
o weight loss,
o decreased sense of well-being
o Chief result: malnutrition, manifested by weight loss and other signs of
vitamin and mineral deficiency (eg, easy bruising, osteoporosis, anemia)
o If untreated: weak and emaciated because of starvation and dehydration
o Failure to absorb the fat-soluble vitamins A, D, and K causes a corresponding
avitaminosis
➢ Medical Management
o avoiding dietary substances that aggravate malabsorption and at
supplementing nutrients that have been lost
o Commons supplements
▪ water-soluble vitamins (eg, B12, folic acid)
▪ fat-soluble vitamins (ie, A, D, and K)
▪ minerals (eg, calcium, iron)
o Dietary therapy
▪ reducing gluten intake for celiac sprue
▪ Folic acid supplements for tropical sprue
o Pharmacologic Therapy
▪ Antibiotics (tetracycline, ampicillin ) treatment of tropical sprue and
bacterial overgrowth syndromes
▪ Antidiarrheal agents - decrease intestinal spasms
▪ Parenteral fluids - treat dehydration
➢ Nursing Management
o provides patient and family education regarding diet and the use of nutritional
supplements
▪ risk of osteoporosis related to malabsorption of calcium
o monitor fluid and electrolyte imbalances.
o conducts ongoing assessments
Acute Inflammatory Intestinal Disorders
➢ Any part of the lower GI tract is susceptible to acute inflammation caused by
bacterial, viral, or fungal infection. Two such situations are appendicitis and
diverticulitis. These two conditions can lead to peritonitis, an inflammatory
process within the abdomen.
APPENDICITIS
➢ appendix becomes inflamed and edematous as a result of either becoming kinked or
occluded by a fecalith (ie, hardened mass of stool), tumor, or foreign body)
➢ inflammation increases intraluminal pressure, initiating a progressively severe,
generalized or upper abdominal pain that becomes localized in the right lower quadrant
of the abdomen within a few hours. Eventually, the inflamed appendix fills with pus
➢ Clinical Manifestations
o Vague epigastric or
periumbilical pain
progresses to RLQ
pain and is usually
accompanied by a
low-grade fever and
nausea and
sometimes by
vomiting
o Loss of appetite
o Local tenderness is
elicited at
McBurney’s point
o Rebound tenderness
o Rovsing’s sign -
elicited by palpating
the left lower
quadrant; this
paradoxically causes
pain to be felt in the
right lower quadrant
➢ Assessment and Diagnostic Findings
o complete physical examination and on laboratory and x-ray findings
o CBC
▪ elevated white blood cell count
▪ leukocytes exceed 10,000 cells/mm3, and the neutrophil count may exceed
75%.
o Abdominal x-ray films, ultrasound studies, and CT scans
➢ Complications
o perforation of the appendix
▪ peritonitis or an abscess
▪ Symptoms
• fever of 37.7°C (100°F) or higher
• a toxic appearance
• continued abdominal pain or tenderness.
➢ Medical Management
o Surgery: Appendectomy - low abdominal incision or by laparoscopy
o antibiotics
o intravenous fluids
o Analgesics – given after diagnosis has been made
➢ Nursing Management
o Goals
▪ relieving pain
▪ preventing fluid volume deficit
▪ reducing anxiety
▪ eliminating infection from the potential or actual disruption of the GI tract
▪ maintaining skin integrity
▪ attaining optimal nutrition
o prepares the patient for surgery
▪ NO ENEMA – it can lead to perforation
▪ Insert NGT if with likelihood of paralytic ileus
o After surgery
▪ semi-Fowler position
▪ administer opioid (morphine sulphate)
▪ oral fluids once indicated
▪ instructs the patient to make an appointment to have the surgeon remove
the sutures
▪ Incision care and activity guidelines
o If with peritonitis
▪ Left with drain
▪monitored carefully for signs of intestinal obstruction or secondary
hemorrhage
o home care
▪ teaches the patient and family to care for the incision and perform dressing
changes and irrigations
▪ monitor for potential complications
DIVERTICULAR DISEASE
➢ Diverticulum (Diverticula)
o saclike outpouching of the lining of the bowel that extends through a
defect in the muscle layer
o may occur anywhere along the GI tract
➢ Diverticulosis
o multiple diverticula are present without inflammation or symptoms
➢ Diverticulitis
o results when food and bacteria retained in a diverticulum produce
infection and inflammation that can impede drainage and lead to
perforation or abscess formation
➢ Pathophysiology
o Causes
▪ forms when the mucosa and submucosal layers of the colon herniate
through the muscular wall because of:
• high intraluminal pressure
• low volume in the colon (ie, fiber-deficient contents)
• decreased muscle strength in the colon wall (ie, muscular
hypertrophy from hardened fecal masses)
o potential complications (symptoms)—abscesses, fistulas, obstruction, and
hemorrhage
➢ Clinical Manifestations
o bowel irregularity and intervals of diarrhea
o abrupt onset of crampy pain in the left lower quadrant of the abdomen
o a low-grade fever
o nausea and anorexia
o bloating or abdominal distention
o Weakness, fatigue, and anorexia
o Mild to severe pain
➢ Medical Management
o DIETARY AND MEDICATION
MANAGEMENT
▪ rest, analgesics (opioid), and
antispasmodics (propantheline
bromide)
▪ diet is clear liquid until the
inflammation subsides
▪ a high-fiber, low-fat diet is
recommended
▪ Antibiotics are prescribed for
7 to 10 days
▪ Bulk-forming laxative
o SURGICAL MANAGEMENT
▪ One-stage resection - inflamed area is removed and a primary end-to-end
anastomosis is completed
▪ Multiple-staged procedures for complications such as obstruction or
perforation
PERITONITIS
➢ inflammation of the peritoneum, the serous
membrane lining the abdominal cavity a nd
covering the viscera
➢ CAUSES
o bacterial infection (Escherichia coli,
Klebsiella, Proteus, and Pseudomonas)
o external sources such as injury or trauma
(eg, gunshot wound, stab wound)
o an inflammation that extends from an
organ outside the peritoneal area
o appendicitis
o perforated ulcer
o diverticulitis
o bowel perforation
o associated with abdominal surgical
procedures and peritoneal dialysis.
➢ Pathophysiology
o leakage of contents from abdominal organs into the abdominal cavity, usually as a
result of inflammation, infection, ischemia, trauma, or tumor perforation
➢ Clinical Manifestations
o Abdominal tenderness and distended, and the muscles become rigid
o Rebound tenderness and paralytic ileus
o nausea and vomiting
➢ Assessment and Diagnostic Findings
o leukocyte count is elevated
o abdominal x-ray is obtained
o CT scan of the abdomen
o Peritoneal aspiration and culture and sensitivity
➢ Complications
o Sepsis is the major cause of death from peritonitis
o Shock may result from septicemia or hypovolemia
o postoperative complications: wound evisceration and abscess formation
➢ Medical Management
o Fluid, colloid, and electrolyte replacement
o isotonic solution
o Analgesics
o Antiemetics
o Massive antibiotic therapy
o Surgical treatment
▪ excision (ie, appendix)
▪ resection with or without anastomosis (ie, intestine)
▪ repair (ie, perforation)
▪ drainage (ie, abscess)
➢ Nursing Management
o Ongoing assessment of pain, vital signs, GI function, and fluid and electrolyte
balance
o Administering analgesic medication and positioning the patient for comfort are
helpful in decreasing pain
o placed on the side with knees flexed
o Accurate recording of all intake and output
o administers and monitors closely intravenous fluids
o increases fluid and food intake gradually and reduces parenteral fluids as
prescribed
o Post-operative Care
▪ observe and record the character of the drainage postoperatively
▪ be cautious when moving and turning the patient to prevent the drains
from being dislodged
▪ prepare the patient and family for discharge by teaching the patient to care
for the incision and drains if the patient will be sent home with the drains
still in place
Inflammatory Bowel Disease
➢ regional enteritis (ie, Crohn’s disease or granulomatous colitis)
➢ ulcerative colitis
REGIONAL ENTERITIS (CROHN’S DISEASE)
➢ a subacute and chronic inflammation that extends through all layers (ie, transmural
lesion) of the bowel wall from the intestinal mucosa
➢ characterized by periods of remissions and exacerbations
➢ Clinical Manifestations
o prominent lower right quadrant abdominal pain and diarrhea unrelieved by
defecation
o crampy abdominal pains
o diarrhea
o steatorrhea
o anorexia
o weight loss
o nutritional deficiencies
➢ Assessment and Diagnostic Findings
o barium study of the upper GI tract – most conclusive
o proctosigmoidoscopic examination
o stool examination
➢ Complications
o intestinal obstruction or stricture formation
o perianal disease
o fluid and electrolyte imbalances
o malnutrition from malabsorption
o fistula and abscess formation
ULCERATIVE COLITIS
➢ a recurrent ulcerative and inflammatory disease of the mucosal and submucosal layers of
the colon and rectum
➢ characterized by multiple ulcerations, diffuse inflammations, and desquamation or
shedding of the colonic epithelium
➢ Clinical Manifestations
o Diarrhea
o lower left quadrant abdominal pain
o intermittent tenesmus
o rectal bleeding
o anorexia
o weight loss
o fever
o vomiting
o dehydration
o feeling of an urgent need to defecate
o passage of 10 to 20 liquid stools each day
➢ Complications
o toxic megacolon
o perforation
o bleeding as a result of ulceration
o vascular engorgement
o highly vascular granulation tissue
Medical Management of Chronic Inflammatory Bowel Disease
➢ Goals
o reducing inflammation
o suppressing inappropriate immune responses
o providing rest for a diseased bowel so that healing may take place
o improving quality of life
o preventing or minimizing complications
➢ NUTRITIONAL THERAPY
o Oral fluids and a low-residue, high-protein, high-calorie diet with supplemental
vitamin therapy and iron replacement
o intravenous therapy
o Cold foods and smoking
o Parenteral nutrition as indicated
➢ PHARMACOLOGIC THERAPY
o Sedatives and antidiarrheal and antiperistaltic medications
o Aminosalicylate formulations: sulfasalazine (Azulfidine)
o sulfa-free aminosalicylates (eg, mesalamine [Asacol, Pentasa])
o corticosteroids (eg, prednisone)
o Immunomodulators (eg, azathioprene [Imuran], 6-mercaptopurine, methotrexate,
cyclosporin)
➢ SURGICAL MANAGEMENT
o total colectomy and ileostomy – procedure of choice for regional enteritis
o intestinal transplant
o Proctocolectomy with ileostomy (ie, complete excision of colon, rectum, and
anus) is recommended when the rectum is severely involved.
o Strictureplasty - the blocked or narrowed section of the bowel is widened, leaving
the bowel intact
o Total Colectomy with Ileostomy
▪ Ileostomy - surgical creation of an opening into the ileum or small
intestine (usually by means of an ileal stoma on the abdominal wall)
▪ allows for drainage of fecal matter (ie, effluent) from the ileum to the
outside of the body
▪ drainage is very mushy and occurs at frequent intervals.
o Total Colectomy with Continent Ileostomy.
▪ removal of the entire colon and creation of the continent ileal reservoir (ie,
Kock pouch)
▪ eliminates the need for an
external fecal collection
bag
▪ Approximately 30 cm of
the distal ileum is
reconstructed to form a
reservoir with a nipple
valve that is created by
pulling a portion of the
terminal ileal loop back
into the ileum.
▪ GI effluent can
accumulate in the pouch
for several hours and then
be removed by means of a
catheter inserted through
the nipple valve
o Total Colectomy with Ileoanal
Anastomosis
▪ A total colectomy with
ileoanal anastomosis is
another surgical
procedure that eliminates the need for a permanent ileostomy
▪ establishes an ileal reservoir, and anal sphincter control of elimination is
retained
▪ connecting a portion of the ileum to the anus (ie, ileoanal anastomosis) in
conjunction with removal of the colon and the rectal mucosa (ie, total
abdominal colectomy and mucosal proctectomy)
▪ the diseased colon and rectum are removed, voluntary defecation is
maintained, and anal continence is preserved
➢ Nursing Management
o education about diet and medications and referral to support groups
o careful monitoring, parenteral nutrition, fluid replacement, and possibly emergent
surgery
o needs for physical care, emotional support, and extensive teaching about
management of the ostomy
MANAGEMENT OF PATIENTS WITH DIGESTIVE AND GASTROINTESTINAL
DISORDERS
Kicking it Off!
I. Anatomy of the
Gastrointestinal Tract
II. Functions
a. To break down food
particles into the
molecular form for
digestion
b. To absorb into the
bloodstream the small
molecules produced by
digestion
c. To eliminate undigested
and unabsorbed
foodstuffs and other
waste products from the
body
CHEWING AND SWALLOWING
• Chewing - food is broken down into small particles that can
be swallowed and mixed with digestive enzymes
• Swallowing
o begins as a voluntary act that is regulated by a swallowing
center in the medulla oblongata of the central nervous system.
o the epiglottis moves to cover the tracheal opening and prevent
aspiration of food into the lungs
o The smooth muscle in the wall of the esophagus contracts in a
rhythmic sequence from the upper esophagus toward the
stomach to propel the bolus of food along the tract
GASTRIC FUNCTION
• Ingestion of food
• The stomach can produce about 2.4 L per day of these
gastric secretions.
Gastric secretions also contain the enzyme pepsin, which
is important for initiating protein digestion
• Intrinsic factor is also secreted by the gastric mucosa.
This compound combines with dietary vitamin B12 so that
the vitamin can be absorbed in the
ileum. In the absence of intrinsic factor, vitamin B12
cannot be absorbed and pernicious anemia results.
• Food mixed with gastric secretions is called chyme.
• Hormones, neuroregulators, and local regulators found in
the gastric secretions control the rate of gastric secretions
and influence gastric motility
COLONIC FUNCTION
• Within 4 hours after eating, residual waste material passes into
the terminal ileum and passes slowly into the proximal portion
of the colon through the ileocecal valve
• The waste materials from a meal eventually reach and distend
the rectum, usually in about 12 hours.
• As much as one fourth of the waste materials from a meal may
still be in the rectum 3 days after the meal was ingested.
WASTE PRODUCTS OF DIGESTION
• Fecal matter is about 75% fluid and 25% solid material.
• Large portion of the fecal mass is of nondietary origin,
derived from the secretions of the GI tract.
• The brown color of the feces results from the breakdown of
bile by the intestinal bacteria. Chemicals formed by intestinal
bacteria (especially indole and skatole) are responsible in
large part for the fecal odor.
• Gases formed contain methane, hydrogen sulfide, and
ammonia, among others.
• The GI tract normally contains approximately 150 mL of
these gases, which are either absorbed into the portal
circulation and detoxified by the liver or expelled from the
rectum as flatus.
• Elimination of stool begins with distention of the rectum,
which reflexively initiates contractions of the rectal
musculature and relaxes the normally closed internal anal
sphincter.
• The internal sphincter is controlled by the autonomic nervous
system; the external sphincter is under the conscious control
of the cerebral cortex.
• During defecation, the external anal sphincter voluntarily
relaxes to allow colonic contents to be expelled.
• Normally, the external anal sphincter is maintained in a state
of tonic contraction. Thus, defecation is seen to be a spinal
reflex (involving the parasympathetic nerve fibers) that can
be inhibited voluntarily by keeping the external anal
sphincter closed.
• Contracting the abdominal muscles (straining) facilitates
emptying of the colon. The average frequency of defecation
in humans is once daily, but the frequency varies among
individuals.
LET’S START THE NURSING PROCESS!
ASSESSMENT
HEALTH HISTORY AND CLINICAL MANIFESTATIONS
Activity 1: Taking History
PAIN
What to ask?
• Character
• Duration
• Pattern
• Frequency
• Location
• Distribution of referred pain
• Time of the pain
What are the factors:
• Meals
• Rest
• Defecation
• Vascular disorders
INDIGESTION
• Upper abdominal discomfort or distress associated with
eating
• Basis: gastric peristaltic movements
• Bowel movements may or may not relieve the pain
• Causes: disturbed nervous system control of the stomach or
disorder in the GI tract or elsewhere in the body
o Fatty foods tend to cause the most discomfort, because
they remain in the stomach longer than proteins or
carbohydrates do.
o Coarse vegetables and highly seasoned foods can
also cause considerable distress.
INTESTINAL GAS
• accumulation of gas in the GI tract may result in:
o belching - the expulsion of gas from the stomach
through the mouth
o flatulence - the expulsion of gas from the rectum
• Excessive flatulence may be a symptom of gallbladder
disease or food intolerance.
PHYSICAL ASSESSMENT
Inspection of the anal and perineal What sounds will you hear during percussion?
area • tympany
• inspect and palpate areas • dullness
of excoriation or rash,
fissures or fistula How to palpate?
openings, or external light palpation - identifying areas of tenderness or swelling
hemorrhoids deep palpation - identify masses in any of the four quadrants.
Inspection-Auscultation-Palpation-
Percussion
DIAGNOSTIC EVALUATION
3. Stool Tests
• Stool Exam/Fecalysis
• Occult Blood
• Specific Tests
• Urobilinogen
• Fat
• Nitrogen
• Parasites
• Pathogens
• food residues
• other substances
• Nursing Responsibilities
• Stool Samples
• randomly collected unless for quantitative study
(fat, urobilinogen)
• quantitative 24- to 72-hour collections must
be kept refrigerated until they are taken to the
laboratory
• Some stool collections require the patient to
follow a special diet or to refrain from taking
certain medications before the collection. It is
important to follow test guidelines closely for
accurate results.
• Fecal occult blood testing- tests for heme, the iron-
containing portion of the hemoglobin molecule that
is altered during transit through the intestines.
• NOT performed when there is hemorrhoidal
bleeding.
• Serial 3- to 6-day testing is recommended.
• False-positive results may occur if the patient
has eaten rare meat, liver, poultry, turnips,
broccoli, cauliflower, melons, salmon,
sardines, or horseradish within 7 days before
testing.
• Medications that can cause gastric irritation,
such as aspirin, ibuprofen, indomethacin,
colchicine, corticosteroids, cancer
chemotherapeutic agents, and
anticoagulants, may also cause false-positive
results.
• Ingestion of vitamin C from supplements or
foods can cause false-negative results.
4. Breath Tests
• hydrogen breath test
• evaluate carbohydrate absorption
• used to aid in the diagnosis of bacterial
overgrowth in the intestine and short bowel
syndrome.
• determines the amount of hydrogen expelled in
the breath after it has been produced in the colon
(on contact of galactose with fermenting bacteria)
and absorbed into the blood
• Urea breath tests
• detect the presence of Helicobacter pylori
• patient takes a capsule of carbon-labeled urea and
then provides a breath sample 10 to 20 minutes
later
• What to avoid?
• antibiotics or loperamide (Pepto-Bismol) for
1 month before the test
• sucralfate (Carafate) and omeprazole
(Prilosec) for 1 week before the test
• cimetidine (Tagamet), famotidine (Pepcid),
ranitidine (Zantac), and nizatidine (Axid) for
24 hours before urea breath testing
5. ABDOMINAL ULTRASONOGRAPHY
• noninvasive diagnostic technique
• used to indicate the size and configuration of abdominal
structures
• useful in the detection of cholelithiasis, cholecystitis,
and appendicitis
• useful in diagnosing acute colonic diverticulitis
• no ionizing radiation, there are no noticeable side
effects, and it is relatively inexpensive
• it cannot be used to examine structures that lie behind
bony tissue
• Gas and fluid in the abdomen or air in the lungs also
prevent transmission of ultrasound
• Endoscopic ultrasonography (EUS) is a specialized
enteroscopic procedure that aids in the diagnosis of GI
disorders by providing direct imaging of a target area
• better quality resolution and definition than regular
ultrasound imaging
• helps in staging of a tumor, including size, spread,
and whether the tumor is operable
• useful in evaluating transmural changes in the
bowel wall that occur in ulcerative colitis
• Nursing Interventions
• fasts for 8 to 12 hours before the test
• If gallbladder studies are being performed, the
patient should eat a fat-free meal the evening
before the test
• If barium studies are to be performed, the nurse
should make sure they are scheduled after the
ultrasound
6. DNA TESTING
• genetic risk assessment, preclinical diagnosis, and
prenatal diagnosis
• DNA testing allows practitioners to prevent (or
minimize) disease, by intervening before its onset, and
to improve therapy
• Computed Tomography
• provides cross-sectional images of abdominal
organs and structures
• valuable tool for detecting and localizing many
inflammatory conditions in the colon, such as
appendicitis, diverticulitis, regional enteritis, and
ulcerative colitis
• NURSING INTERVENTIONS
• patient should not eat or drink for 6 to 8 hours
before the test.
• practitioner may prescribe an intravenous or
oral contrast agent
• nurse should question the patient about
contrast dye allergies
• If barium studies are to be performed, it is
important to schedule them after CT
scanning, so as not to interfere with imaging.
8. ENDOSCOPIC PROCEDURES:
fibroscopy/esophagogastroduodenoscopy, anoscopy,
proctoscopy, sigmoidoscopy, colonoscopy, small-bowel
enteroscopy, and endoscopy through ostomy
• Fiberoptic Colonoscopy
o Direct visual inspection of the colon to the cecum is
possible by means of a flexible fiberoptic
colonoscope
o most frequently used for cancer screening
o tissue biopsies can be obtained as needed, and
polyps can be removed and evaluated
o Nursing Interventions
▪ patient should limit the intake of liquids for 24 to
72 hours before the examination
▪ laxative for two nights before the examination
and a Fleet’s or saline enema until the return
runs clear the morning of the test
▪ polyethylene glycol electrolyte lavage solutions
(Golytely, Colyte, NuLytely) are used as
intestinal lavages for effective cleansing of the
bowel
▪ Informed consent is obtained before the test.
▪ NPO
▪ performed while the patient is lying on the left
side with the legs drawn up toward the chest
▪ monitor the patient’s cardiac and respiratory
function continuously
▪ Oxygen saturation is monitored; Supplement as
needed
• Small-Bowel Enteroscopy
o “pull” endoscope - balloon tip advances the scope by
peristalsis through the small intestine
o “Push” endoscopes - smaller in caliber and longer in
length, while still allowing the use of biopsy forceps
and probes
o useful in the evaluation of patients who have
continued bleeding even after extensive diagnostic
testing has identified no other problem area
o can also be used when biopsy of the small bowel is
needed to diagnose malabsorption syndromes.
MALOCCLUSION
➢ Malocclusion is a misalignment of the teeth of the upper and lower
dental arcs when the jaws are closed.
➢ Malocclusion can be inherited or acquired (from thumb-sucking,
trauma, or some medical conditions).
➢ Correction of malocclusion requires an orthodontist with special
training, a patient who is motivated and cooperative, and adequate
time.
➢ Most treatments begin when the patient has shed the last primary
tooth and the last permanent successor has erupted, usually at
about 12 or 13 years of age, but treatment may occur in
adulthood.
➢ Management
• Braces
• Retaining device
➢ Nursing Responsibilities
• Instruct to practice meticulous oral hygiene
• Encourages to persist in this important part of the treatment.
• Remind to continue wearing the retainer
Disorders of the Lips, Mouth and Gums
-
Disorders of the Jaw
➢ congenital malformation, fracture, chronic dislocation, cancer, and
syndromes characterized by pain and limited motion
TEMPOROMANDIBULAR DISORDERS
➢ Categories:
o Myofascial pain—a discomfort in the muscles controlling jaw
function and in neck and shoulder muscles
o Internal derangement of the joint—a dislocated jaw, a displaced
disc, or an injured condyle
o Degenerative joint disease—rheumatoid arthritis or
osteoarthritis in the jaw joint
➢ Clinical Manifestations
o pain ranging from a dull ache to throbbing, debilitating pain that
can radiate to the ears, teeth, neck muscles, and facial sinuses
o often have restricted jaw motion and locking of the jaw.
o may hear clicking and grating noises, and chewing and
swallowing may be difficult
o Depression may occur in response to these symptoms
➢ Assessment
o based on subjective symptoms of pain, limitations in range of
motion, dysphagia, difficulty chewing, difficulty with speech, or
hearing difficulties
➢ Diagnostics
o MRI
o X-ray
➢ Management
o patient education in stress management may be helpful (to
reduce grinding and clenching of teeth)
o range-of-motion exercises
o Pain management measures
▪ nonsteroidal anti-inflammatory drugs (NSAIDs), with the
possible addition of opioids, muscle relaxants, or mild
antidepressants
o bite plate or splint (plastic guard worn over the upper and lower
teeth) may be worn to protect teeth from grinding
o Surgical Management
▪ repositioning or reconstruction of the jaw
▪ Rigid plate fixation (insertion of metal plates and screws
into the bone to approximate and stabilize the bone)
▪ Bone grafting
o Nursing Management
▪ Instruct not to chew food in the first 1 to 4 weeks after
surgery
▪ A liquid diet is recommended, and dietary counseling
should be obtained to ensure optimal caloric and protein
intake
▪ Promoting home and community-based care
• mouth care and feeding
• Consultation with a dietitian
• Nutritional supplements